Skip to main content
. 2013 Sep 4;2013:457834. doi: 10.1155/2013/457834

Table 1.

Hematological and biochemical data for the study patients comprised 170 with iron deficiency anemia (IDA), 200 β-thalassemia carriers, 65 α-thalassemia carriers, and 45 mixed clinical situations (hemoglobinopathy and other disease, iron deficiency, or pregnancy). Values are reported as mean (standard deviation).

Mixeda β-thalassemiab IDAc α-thalassemiad P value
RBC, 1012/L 5.70 5.79 4.72 5.40 <0.001
(0.57)c,d (0.54)c,d (0.48)all (0.55)all
Hb, g/L 116 119 105 123 <0.001
(13.2)d (11.2)d (11.0)c,d (14.0)all
MCV, fL 64.6 64.6 73.7 70.5 <0.001
(4.08)c,d (3.39)c,d (4.63)all (2.96)all
MCH, pg 20.4 20.6 22.3 22.7 <0.001
(1.48)c,d (1.11)c,d (1.86)a,b (1.08)a,b
RDW, % 16.9 16.1 18.2 15.9 <0.001
(1.84)c (1.06)c (3.03)all (1.51)c

RBC: Red Blood Cells; Hb: hemoglobin; MCV: mean cell volume; MCH: mean cell hemoglobin; RDW: RBC distribution width.

Superscript letters (a,b,c,d,all) indicate significant differences between groups.

P < 0.001 was for the studied blood markers for the mean differences between acquired (IDA) and genetic anemia.